AI-powered, load-and-go platform has potential to radically shift how veterinarians process, diagnose, and act on cytology and blood morphology cases The global launch of the IDEXX inVue Dx analyzer ...
Fast, effortless operation and a small footprint make consistent, accurate in-clinic hematology results accessible to veterinarians worldwide "ProCyte One reimagines point-of-care hematology with a ...
WESTBROOK, Maine - IDEXX Laboratories, Inc. (NASDAQ: IDXX) has announced the introduction of the IDEXX inVue Dx™ Cellular Analyzer. This new device is touted as a revolutionary tool for veterinary ...
Growth through innovation is a core strategy for Idexx Laboratories Inc., a Westbrook, Maine-based manufacturer of diagnostic instruments and software for veterinarians. Thanks to a steady stream of ...
Hosted on MSN
Idexx raises 2025 revenue outlook to $4.28B as inVue Dx placements surge and innovation momentum builds
Jonathan J. Mazelsky, CEO, highlighted, "IDEXX delivered a very strong quarter of performance as reflected in solid execution across all key drivers of our strategy." He emphasized rapid adoption of ...
IDEXX Laboratories, Inc. IDXX recently expanded its Fecal Dx antigen testing platform with the addition of Cystoisospora — a common intestinal parasite that is the source of diarrhea, weight loss and ...
IDEXX Laboratories, Inc. IDXX is well-poised to grow confidence, backed by solid gains in CAG (Companion Animal Group) Diagnostics’ recurring revenues. Strong momentum in the expansion of the ProCyte ...
Fast, effortless operation and a small footprint make consistent, accurate in-clinic hematology results accessible to veterinarians worldwide WESTBROOK, Maine, Aug. 12, 2020 /PRNewswire/ -- IDEXX ...
WESTBROOK, Maine, Aug. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today the launch of the ProCyte One™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback